AstraZeneca PLC
LSE:AZN
Gross Margin
AstraZeneca PLC
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Gross Margin Comparison
AstraZeneca PLC Competitors
Country | UK |
Market Cap | 185.9B GBP |
Gross Margin |
82%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Gross Margin |
-3%
|
Country | US |
Market Cap | 688.2B USD |
Gross Margin |
79%
|
Country | DK |
Market Cap | 3.9T DKK |
Gross Margin |
85%
|
Country | UK |
Market Cap | 440.4B GBP |
Gross Margin |
56%
|
Country | JP |
Market Cap | 82T JPY |
Gross Margin |
57%
|
Country | US |
Market Cap | 353.4B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 330.9B USD |
Gross Margin |
74%
|
Country | CH |
Market Cap | 183B CHF |
Gross Margin |
74%
|
Country | CH |
Market Cap | 175.5B CHF |
Gross Margin |
74%
|
Country | US |
Market Cap | 142.6B USD |
Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for AstraZeneca PLC.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on AstraZeneca PLC's most recent financial statements, the company has Gross Margin of 82.4%.